Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol
Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, Victoria 3010, Australia. The Journal of Pathology
(Impact Factor: 7.43).
04/2007; 211(5):582-90. DOI: 10.1002/path.2145
Prion diseases are fatal, transmissible neurodegenerative disorders associated with conversion of the host-encoded prion protein (PrP(C)) into an abnormal pathogenic isoform (PrP(Sc)). Following exposure to the infectious agent (PrP(Sc)) in acquired disease, infection is propagated in lymphoid tissues prior to neuroinvasion and spread within the central nervous system. The mechanism of prion dissemination is perplexing due to the lack of plausible PrP(Sc)-containing mobile cells that could account for prion spread between infected and uninfected tissues. Evidence exists to demonstrate that the culture media of prion-infected neuronal cells contain PrP(Sc) and infectivity but the nature of the infectivity remains unknown. In this study we have identified PrP(C) and PrP(Sc) in association with endogenously expressing PrP neuronal cell-derived exosomes. The exosomes from our prion-infected neuronal cell line were efficient initiators of prion propagation in uninfected recipient cells and to non-neuronal cells. Moreover, our neuronal cell line was susceptible to infection by non-neuronal cell-derived exosome PrP(Sc). Importantly, these exosomes produced prion disease when inoculated into mice. Exosome-associated PrP is packaged via a novel processing pathway that involves the N-terminal modification of PrP and selection of distinct PrP glycoforms for incorporation into these vesicles. These data extend our understanding of the relationship between PrP and exosomes by showing that exosomes can establish infection in both neighbouring and distant cell types and highlight the potential contribution of differentially processed forms of PrP in disease distribution. These data suggest that exosomes represent a potent pool of prion infectivity and provide a mechanism for studying prion spread and PrP processing in cells endogenously expressing PrP.
Figures in this publication
Available from: Elena Vallino Costassa
- "In recent years, it has been demonstrated that PrP is associated with exosomes, small membrane vesicles of endocytic origin which play an important role in intercellular communication . PrP is associated with exosomes secreted from non-neuronal and neuronal cells (Fevrier et al., 2004; Leblanc et al., 2006; Wang et al., 2011), and exosomes containing PrP Sc are capable of transferring infectivity to cells (Vella et al., 2007; Alais et al., 2008). Despite the unequivocal presence of blood infectivity of prion-affected individuals, PrP detection might be masked by proteins or soluble components of plasma (Abdel-Haq, 2015; Gregori et al., 2008; Orrú et al., 2011; Properzi et al., 2015; Saá et al., 2014). "
[Show abstract] [Hide abstract]
ABSTRACT: Prion protein (PrP) is present at extremely low levels in the blood of animals and its detection is complicated by the poor sensitivity of current standard methodologies. Interesting results have been obtained with recent advanced technologies that are able to detect minute amounts of the pathological PrP (PrPSc), but their efficiency is reduced by various factors present in blood. In this study, we were able to extract cellular PrP (PrPC) from plasma-derived exosomes by a simple, fast method without the use of differential ultracentrifugation and to visualize it by Western blotting, reducing the presence of most plasma proteins. This result confirms that blood is capable of releasing PrP in association with exosomes and could be useful to better study its role in TSEs pathogenesis.
Available from: Alexander Vlassov
- "Depending on the cell or tissue of origin, many different roles and functions have been attributed to exosomes—to name a few: eradication of obsolete molecules, facilitation of the immune response (Théry et al. 2009), antigen presentation, programmed cell death, angiogenesis, inflammation, coagulation , dissemination of oncogenes from tumor cells, and spread of pathogens such as prions and viruses from one cell to another (Vella et al. 2007). Most importantly, exosomes have been shown to deliver macromolecular messages (RNA and protein), enabling cell-to-cell communication and signaling (Vlassov et al. 2012). "
[Show abstract] [Hide abstract]
ABSTRACT: Exosomes are tiny vesicles (diameter 30-150 nm) secreted by cells in culture and found in all body fluids. These vesicles, loaded with unique RNA and protein cargos, have many biological functions, of which only a small fraction is currently understood-for example, they participate in cell-to-cell communication and signaling within the human body. The spectrum of current scientific interest in exosomes is wide and ranges from understanding their functions and pathways to using them in diagnostics, as biomarkers, and in the development of therapeutics. Here we provide an overview of different strategies for isolation of exosomes from cell-culture media and body fluids.
© 2015 Cold Spring Harbor Laboratory Press.
Available from: Fabio Falsone
- "It seems that the exosome-mediated secretion of amyloidassociated proteins is an organized process, as it can be triggered by determinate signaling events, such as calcium release (Emmanouilidou et al., 2010), or platelet activation (Robertson et al., 2006). Of fundamental importance, PrP sc or aSyn oligomers isolated from exosomes retain full toxicity, suggesting that these organelles can indeed serve as infectious vehicles (Fevrier et al., 2004; Vella et al., 2007; Danzer et al., 2012). "
[Show abstract] [Hide abstract]
ABSTRACT: Many neurodegenerative disorders are linked to irreversible protein aggregation, a process that usually comes along with toxicity and serious cellular damage. However, it is emerging that protein aggregation can also serve for physiological purposes, as impressively shown for prions. While the aggregation of this protein family was initially considered exclusively toxic in mammalians organisms, it is now almost clear that many other proteins adopt prion-like attributes to rationally polymerize into higher order complexes with organized physiologic roles. This implies that cells can tolerate at least in some measure the accumulation of inherently dangerous protein aggregates for functional profit. This review summarizes currently known strategies that living organisms adopt to preserve beneficial aggregation, and to prevent the catastrophic accumulation of toxic aggregates that frequently accompany neurodegeneration.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.